Taken together, our study suggests an important role of CIRP in the development of heart failure and demonstrated a beneficial effect of CIRP agonist zr17-2 in preventing the development of heart failure in the context of MI conditions, possibly via anti-inflammatory and anti-oxidant pathways. The gene discussed is CIRBP; the disease is myocardial infarction.